REFERENCES
- McGehee RF JR, Smith CB, Wilcox C, Et Al: Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Amer J Med Sci 256: 279, 1968
- Wagner JG, Novak E, Patel NC, Et Al: Absorption, excretion and half-life of clinimycin in normal adult males. Amer J Med Sci 256: 25, 1968
- Meyers BR, Kaplan K, Weinstein L: Microbiological and pharmacological behavior of 7-chlorolincomycin. Appl Microbiol 17: 653, 1969
- Plott Ma, Roth H: Penetration of clindamycin into synovial fluid. Clin Pharmacol Ther 11: 577, 1970
- Oppenheimer S, Turek M: Laboratory and clinical evaluation of 7-chloro-7-deoxylincomycin. Amer J Med Sci 256: 314, 1968
- Matsen Jm: In vitro study of clindamycin and 5 other lincomycin analogs against strains of Haemophilus influenzae. J Lab Clin Med (in press)
- Berman JD, Levine MK: The efficacy of clindamycin in beta-hemolytic streptococcal infections of the upper respiratory tract. J Med Ass Georgia 58: 155, 1969
- Stiver HG, Ronald AR: Clindamycin: clinical and laboratory experience. Twentieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Oct 1970
- Wick WE, Boniece WS: In vitro and in vivo laboratory evaluation of cephaloglycin and cephaloridine. Appl Microbiol 13: 248, 1965
- Applestein JM, Crosby EB, Johnson WD, Et Al: In vitro antimicrobial activity and human pharmacology of cephaloglycin. Appl Microbiol 16: 1006, 1968
- Perkins RL, Glontz GE, Saslaw S: Cephaloglycin: crossover absorption studies and clinical evaluation. Clin Pharmacol Ther 10: 244, 1969
- Hogan Lb JR, Holloway WJ, Jakubowitch RA: Clinical experience with cephaloglycin. Antimicrob Agents Chemother 7: 624, 1967
- Landes RR, Melnick I, Fletcher A, Et Al: Cephaloglycin: a new orally effective antibiotic for urinary tract infections. J Urol 102: 246, 1969
- Pitt J, Siasoco R, Kaplan K, Et Al: Antimicrobial activity and pharmacological behavior of cephaloglycine. Antimicrob Agents Chemother 7: 630–635, 1967
- Johnson WD, Applestein JM, Kaye D: Cephaloglycin. Clinical and laboratory experience with an Orally Administered Cephalosporin. Jama 206: 2698, 1968
- Ronald AR, Kind AC, Turck M: Cephaloglycin in infections of the urinary tract. Arch Intern Med 121: 39, 1968
- Stillerman M: Comparison of cephaloglycin and penicillin in streptococcal pharyngitis. Clin Pharmacol Ther 11: 205, 1970
- Med Lett Drugs Ther 12, 2 Oct 1970
- Matsen JM: Cephaloglycin in pediatric patients. Amer J Dis Child (in press)
- Smith CB, Wilfert JN, Dans PE, Et Al: In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin. J Infect Dis 122: suppl: S14–28, Sept 1970
- Standiford HC, Jordan MC, Kirby WM: Clinical pharmacology of carbenicillin compared with other penicillins. Ibid.,20 pp S9–13
- Bodey GP, Rodriguez V, Whitecar JP: Severe infections in leukemic patients. In Advances in the Management of Pseudomonas and Proteus Infections. New York, Excerpta Medica Foundation, 1969, p 65
- Hoffman TA, Cestero R, Bullock WE: Pharmacokinetics of carbenicillin in patients with hepatic and renal failure. Ibid,20 pp S75–77
- Duma RJ, Warner JF, Utz JP: Carbenicillin in Pseudomonas aeruginosa respiratory infections. Ibid.,22 p 16
- Boxerbaum B, Doershuk CF, Matthews LW: Use of carbenicillin in patients with cystic fibrosis. Ibid,20 pp S59–61
- Curreri PW, Lindberg RB, Divincenti FC, Et Al: Intravenous administration of carbenicillin for septicemia due to Pseudomonas aeruginosa following thermal injury. Ibid,20 pp S40–47
- Nelson JD: Carbenicillin therapy of infections due to Pseudomonas in children. Ibid,20 pp S48–58
- Turck M, Silverblatt F, Clark H, Et Al: The role of carbenicillin in treatment of infections of the urinary tract. Ibid,20 pp S29–33
- Lowbury EJ, Lilly HA, Kidson A, Et Al: Sensitivity of Pseudomonas aeruginosa to antibiotics. Lancet 2: 448, 1969
- Solbert CO, Kjellstrand KM, Matsen JM: Carbenicillin therapy of severe Pseudomonas aeruginosa infections. J Chronic Dis (in press)